Trombositopenik Hastaya Yaklaşım

(1:45)

First-Line Therapy Options for Patients with ITP

(5:15)

Investigating the Use of Fostamatinib in ITP

(9:47)

Rozanolixizumab to Treat Immune Thrombocytopenia

(5:46)

Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia: Treatments to Watch For | MPN Update

(12:31)

Immune Thrombocytopenia Treatment in Children

(4:59)

Eltrombopag helped reduce bleeding in children with immune thrombocytopenic purpura

(8:25)

ASH Highlights: Efgartigimod Safe and Effective in Treating Immune Thrombocytopenia (ITP)

(2:55)

Watch Drs. Ku, Pant, \u0026 Raghav discuss the latest GI Cancers updates from #GI25 - bit.ly/GIHER2Y

(1:42:43)

Long-term safety and efficacy of sutimlimab for chronic ITP

(4:14)

Immune Thrombocytopenia: First-Line Treatment Options

(3:33)

Essential Thrombocythemia: A Case Study - Jerry L. Spivak, MD

(26:35)

22. Anticoagulation in high bleeding risk cancer patients - Dr Nolukholo Ncete

(30:47)

DIC versus TTP

(9:18)

Second-Line Treatment Options for Patients with ITP

(4:44)

Ordering tests for bleeding coagulopathic patients

(4:10)

The Importance of Platelets During Chemotherapy #short #breastcancer #chemotherapy

(24)

PERSIST-1: Pacritinib Shakes Up the Current Myelofibrosis Treatment Landscape

(5:23)

Pacritinib versus ruxolitinib in patients with myelofibrosis and thrombocytopenia

(1:59)

Ruxolitinib in Patients With Low Platelets:phase 3b Expanded-Access Study in Myelofibrosis

(2:52)